TTF2 Activators
TTF2 Activators are a specialized class of compounds that engage with the transcription termination factor 2 (TTF2), a protein that plays a critical role in the termination of transcription in eukaryotic cells. These activators are characterized by their ability to specifically enhance the functionality of TTF2 without altering its expression levels or initiating a direct interaction with the genetic material. One way these activators function is by stabilizing the protein or facilitating its interaction with other proteins involved in the transcription termination process. For example, certain small molecule activators might increase the affinity of TTF2 for its substrate, thereby accelerating the termination process and ensuring that transcription is efficiently concluded. Another subset of TTF2 activators might work by enhancing the ATPase activity of TTF2, which is essential for its function in transcription termination. By increasing the rate of ATP hydrolysis, these activators indirectly enhance the dynamic actions of TTF2 as it disassembles the transcription machinery and releases the nascent RNA transcript.
Furthermore, TTF2 Activators may exert their effects by modulating associated signaling pathways that influence TTF2's activity. For instance, compounds that alter the phosphorylation state of TTF2 can act as activators. Phosphorylation is a common post-translational modification that can alter protein activity, and by influencing the kinases or phosphatases that target TTF2, these activators can enhance its role in transcription termination. Other activators in this class might interact with molecular chaperones that facilitate the proper folding and localization of TTF2 within the nucleus. Such activators ensure that TTF2 maintains a conformation that is conducive to high activity levels and proper engagement with the transcriptional machinery. Overall, TTF2 Activators encompass a range of chemical entities that, through various biochemical mechanisms, augment the functional activity of TTF2, thereby ensuring that the complex process of transcription termination is carried out with the requisite efficiency and fidelity necessary for cellular homeostasis.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn can enhance the activity of TTF2 by promoting the phosphorylation events required for its transcriptional termination functions. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate proteins in the transcription termination pathways, potentially enhancing the activity of TTF2 in releasing RNA polymerase during transcription termination. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which may activate calcium-dependent kinases that phosphorylate TTF2, thus enhancing its functional activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts similarly to ionomycin by increasing intracellular calcium levels, potentially activating calcium-dependent proteins that can phosphorylate and enhance TTF2 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which increases cAMP by preventing its degradation, potentially enhancing TTF2 activity through cAMP-dependent protein kinase (PKA) mediated pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell, which could enhance the activity of TTF2 through increased phosphorylation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, Calyculin A inhibits protein phosphatases and may result in a higher phosphorylation state of TTF2, potentially enhancing its activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a protein kinase inhibitor, but due to its broad specificity, it might indirectly enhance TTF2 activity by inhibiting kinases that would otherwise negatively regulate TTF2. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analogue that activates PKA, and it could enhance TTF2 activity by promoting PKA-mediated phosphorylation of proteins in its functional pathway. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to increased cAMP levels, potentially enhancing the activity of TTF2 through cAMP-dependent pathways. | ||||||